Dr. Glanz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500Fax+1 617-421-3487
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1975 - 1976
- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1972 - 1975
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1971 - 1972
- Case Western Reserve University School of MedicineClass of 1971
Certifications & Licensure
- CA State Medical License 1975 - Present
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 47 citationsStatin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.David L. McClure, Robert J. Valuck, Morton Glanz, James Murphy, John E. Hokanson
Journal of Clinical Epidemiology. 2007-08-01 - 42 citationsSystematic Review and Meta-Analysis of Clinically Relevant Adverse Events From HMG CoA Reductase Inhibitor Trials Worldwide From 1982 to PresentDavid L. McClure, Robert J. Valuck, Morton Glanz, John E. Hokanson
Pharmacoepidemiology and Drug Safety. 2007-02-01 - 10 citationsMeta-analysis of studies using selective alpha1-blockers in patients with hypertension and type 2 diabetes.Morton Glanz, Garber Aj, Mancia G, Levenstein M
International Journal of Clinical Practice. 2001-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: